What Good is Targeted Cancer Treatment without the Test?
The Canadian Cancer Survivor Network (CCSN) commissioned a review of precision medicine companion diagnostic testing in Canada through a literature review and a series of stakeholder interviews to determine if there were any challenges or barriers that would ultimately impact patient access to companion diagnostics and then issue a series of recommendations to help inform thoughtful change to address those concerns.
Read the full report here.